Internal Medicine, Infectious Disease · Philadelphia, PA
NPI
1740278647
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
301 S 8th St, Suite 1b
Philadelphia, PA, 19106
Phone (215) 829-5354
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
349 services
Medicare patients, 2024
133
Average age 70
Drug cost, 2024
$3.9M
1,699 prescriptions
Company payments, 2024
$20.01
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason J Bofinger was code 99214 (office e&m - established), 94 times for 57 patients. In total Jason J Bofinger billed 349 services in 16 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 94 | 57 | $91.32 | $8,584 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 79 | 48 | $12.53 | $990 |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 39 | $63.82 | $3,638 |
| 99222 Hospital E&M - Initial | Facility | 46 | 44 | $105.97 | $4,875 |
| 99223 Hospital E&M - Initial | Facility | 26 | 25 | $139.84 | $3,636 |
By year: 2022 $35K for 399 services; 2023 $35K for 364 services; 2024 $26K for 349 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason J Bofinger prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 489 prescriptions and refills. In total Jason J Bofinger wrote 1,699 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 489 | 531 | 52 | $2.0M |
| Tivicay Dolutegravir Sodium | 129 | 139 | 18 | $305K |
| Descovy Emtricitabine/Tenofov Alafenam | 116 | 132 | 12 | $280K |
| Doxycycline Monohydrate Generic | 89 | 113 | 18 | $3,972 |
| Cefadroxil Generic | 64 | 75 | 17 | $4,585 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 61 | 67 | Under 11 | $235K |
| Juluca Dolutegravir/Rilpivirine | 52 | 60 | Under 11 | $203K |
| Cefpodoxime Proxetil Generic | 45 | 45 | Under 11 | $4,227 |
| Prezcobix Darunavir/Cobicistat | 36 | 36 | Under 11 | $93K |
| Fluconazole Generic | 35 | 35 | Under 11 | $378 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 31 | 39 | Under 11 | $147K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 30 | 30 | Under 11 | $105K |
| Famotidine Generic | 25 | 25 | Under 11 | $118 |
| Vancomycin Hcl Generic | 24 | 24 | Under 11 | $1,484 |
| Valacyclovir Valacyclovir Hcl | 24 | 42 | Under 11 | $825 |
Brand drugs: 1,060 claims; generic drugs: 639 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jason J Bofinger $20.01 ($20.01 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $20.01.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $20.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.